GLP-1 Drugs Shift from Obesity Treatment to Lifestyle Use | Retatrutide News

GLP-1 receptor agonists are increasingly being used as lifestyle drugs rather than just obesity treatments. This trend may affect the development and re...
Market News · October 17, 2026